Phase 1/2 H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive interim data from a Phase 1/2 clinical study (NCT05972174) evaluating the […]

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / WHY: New York, N.Y., May 28, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE:ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / WHY: New York, N.Y., May 28, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Everus Construction Group, Inc. (NYSE:ECG) between October 31, 2024 and February 11, 2025, both dates inclusive (the "Class Period"), including investors

In partnership with BOCHK Asset Management Limited (BOCHKAM), Premia Partners, the leading homegrown ETF provider from Hong Kong, announces listing of Premia BOCHK Saudi Arabia Government Sukuk ETF(the ETF)on 29 May 2025 on HKEx. As Asia's first investment grade government sukuk ETF, the physical replicated ETF is designed to provide investors with direct access to

Investment made possible by Canadian Industrial and Technological Benefits Policy (ITB) Gastops Ltd. is announcing a joint agreement under Canada's Industrial and Technology Benefits (ITB) policy for a multi-million-dollar investment from RTX. The funding will support a research and development program to advance the next generation of oil debris monitoring (ODM) system technology and future

MUNICH, DE / ACCESS Newswire / May 28, 2025 / Mynaric AG (OTC PINK:MYNAY)(OTC PINK:MOYFF)(ISIN: US62857X1019) (FRA:M0YN)(ISIN: DE000A31C305) (the "Company") announces that the majority of the voting groups at today’s discussion and voting meeting (Erörterungs- und Abstimmungstermin) approved the restructuring plan proposed by the Company in accordance with the German Corporate Stabilization and Restructuring Act

(NasdaqGM:FATE), SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, today announced that clinical and preclinical data from the Company's off-the-shelf cell therapy product platform will be featured at the

Millbrae, May 28, 2025 (GLOBE NEWSWIRE) — Millbrae, California – T.D.E. Wedding, an established leader in Northern California event coordination since 2007, continues to offer engaged couples a rare commodity: peace of mind. Headquartered in Millbrae and led by longtime owner Carol M.Lee, the firm provides full-service wedding planning that transforms dream concepts into reality,

Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress Oral presentation of clinical data from FT819 Phase 1 study highlights safety and efficacy of fludarabine-free treatment paradigm in moderate-to-severe systemic lupus erythematosus (SLE) GlobeNewswire May 28, 2025 SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE)

Bay Area Wedding Planner T.D.E. Wedding Offers Couples a Stress-Free Path to Their Perfect Day GlobeNewswire May 28, 2025 Millbrae, May 28, 2025 (GLOBE NEWSWIRE) — Millbrae, California – T.D.E. Wedding, an established leader in Northern California event coordination since 2007, continues to offer engaged couples a rare commodity: peace of mind. Headquartered in Millbrae